The Survivin saga goes in vivo
AUTOR(ES)
Reed, John C.
FONTE
American Society for Clinical Investigation
ACESSO AO ARTIGO
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=200960Documentos Relacionados
- Inhibition of melanoma tumor growth in vivo by survivin targeting
- Overlapping roles for the histone acetyltransferase activities of SAGA and Elongator in vivo
- SAGA is an essential in vivo target of the yeast acidic activator Gal4p
- The S. cerevisiae SAGA complex functions in vivo as a coactivator for transcriptional activation by Gal4
- Survivin 2α: a novel Survivin splice variant expressed in human malignancies